# Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer

> **NCT00882232** · PHASE1 · COMPLETED · sponsor: **Cancer Center of Irvine** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Cross-linked hyaluronan gel

## Key facts

- **NCT ID:** NCT00882232
- **Lead sponsor:** Cancer Center of Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882232, "Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00882232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*